These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29921733)

  • 1. Aromatase Acetylation Patterns and Altered Activity in Response to Sirtuin Inhibition.
    Molehin D; Castro-Piedras I; Sharma M; Sennoune SR; Arena D; Manna PR; Pruitt K
    Mol Cancer Res; 2018 Oct; 16(10):1530-1542. PubMed ID: 29921733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysine acetylation stoichiometry and proteomics analyses reveal pathways regulated by sirtuin 1 in human cells.
    Gil J; Ramírez-Torres A; Chiappe D; Luna-Peñaloza J; Fernandez-Reyes FC; Arcos-Encarnación B; Contreras S; Encarnación-Guevara S
    J Biol Chem; 2017 Nov; 292(44):18129-18144. PubMed ID: 28893905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylation of conserved DVL-1 lysines regulates its nuclear translocation and binding to gene promoters in triple-negative breast cancer.
    Sharma M; Molehin D; Castro-Piedras I; Martinez EG; Pruitt K
    Sci Rep; 2019 Nov; 9(1):16257. PubMed ID: 31700102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of PARP-1, Histone H1 and SIRT-1 as New Regulators of Breast Cancer-Related Aromatase Promoter I.3/II.
    Kaiser A; Krüger T; Eiselt G; Bechler J; Kniemeyer O; Huber O; Schmidt M
    Cells; 2020 Feb; 9(2):. PubMed ID: 32059481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIRT1 positively regulates breast cancer associated human aromatase (CYP19A1) expression.
    Holloway KR; Barbieri A; Malyarchuk S; Saxena M; Nedeljkovic-Kurepa A; Cameron Mehl M; Wang A; Gu X; Pruitt K
    Mol Endocrinol; 2013 Mar; 27(3):480-90. PubMed ID: 23340254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of the steroidogenic acute regulatory protein in breast cancer: Regulation by histone deacetylase inhibition.
    Manna PR; Ahmed AU; Vartak D; Molehin D; Pruitt K
    Biochem Biophys Res Commun; 2019 Feb; 509(2):476-482. PubMed ID: 30595381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors.
    Lapierre M; Linares A; Dalvai M; Duraffourd C; Bonnet S; Boulahtouf A; Rodriguez C; Jalaguier S; Assou S; Orsetti B; Balaguer P; Maudelonde T; Blache P; Bystricky K; Boulle N; Cavaillès V
    Oncotarget; 2016 Apr; 7(15):19693-708. PubMed ID: 26930713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the carbamate fungicide benomyl on the gene expression and activity of aromatase in the human breast carcinoma cell line MCF-7.
    Kawaratani Y; Matsuoka T; Hirata Y; Fukata N; Nagaoka Y; Uesato S
    Environ Toxicol Pharmacol; 2015 Jan; 39(1):292-9. PubMed ID: 25543211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth.
    Catalano S; Giordano C; Panza S; Chemi F; Bonofiglio D; Lanzino M; Rizza P; Romeo F; Fuqua SA; Maggiolini M; Andò S; Barone I
    Breast Cancer Res Treat; 2014 Jul; 146(2):273-85. PubMed ID: 24928526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoacetylation, hypomethylation, and dephosphorylation of H2B histones and excessive histone deacetylase activity in DU-145 prostate cancer cells.
    Cang S; Xu X; Ma Y; Liu D; Chiao JW
    J Hematol Oncol; 2016 Jan; 9():3. PubMed ID: 26759222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDAC6 Deacetylates HMGN2 to Regulate Stat5a Activity and Breast Cancer Growth.
    Medler TR; Craig JM; Fiorillo AA; Feeney YB; Harrell JC; Clevenger CV
    Mol Cancer Res; 2016 Oct; 14(10):994-1008. PubMed ID: 27358110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDAC7 regulates histone 3 lysine 27 acetylation and transcriptional activity at super-enhancer-associated genes in breast cancer stem cells.
    Caslini C; Hong S; Ban YJ; Chen XS; Ince TA
    Oncogene; 2019 Sep; 38(39):6599-6614. PubMed ID: 31375747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Fungal Metabolite Eurochevalierine, a Sequiterpene Alkaloid, Displays Anti-Cancer Properties through Selective Sirtuin 1/2 Inhibition.
    Schnekenburger M; Mathieu V; Lefranc F; Jang JY; Masi M; Kijjoa A; Evidente A; Kim HJ; Kiss R; Dicato M; Han BW; Diederich M
    Molecules; 2018 Feb; 23(2):. PubMed ID: 29401749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imbalance of Lysine Acetylation Contributes to the Pathogenesis of Parkinson's Disease.
    Wang R; Sun H; Wang G; Ren H
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysine deacetylase inhibition attenuates hypertension and is accompanied by acetylation of mineralocorticoid receptor instead of histone acetylation in spontaneously hypertensive rats.
    Seok YM; Lee HA; Park KM; Hwangbo MH; Kim IK
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul; 389(7):799-808. PubMed ID: 27106211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using Histone Deacetylase Inhibitors to Analyze the Relevance of HDACs for Translation.
    Hutt DM; Roth DM; Marchal C; Bouchecareilh M
    Methods Mol Biol; 2017; 1510():77-91. PubMed ID: 27761814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Troglitazone inhibits histone deacetylase activity in breast cancer cells.
    Davies GF; Ross AR; Arnason TG; Juurlink BH; Harkness TA
    Cancer Lett; 2010 Feb; 288(2):236-50. PubMed ID: 19699029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical acetylation and deacetylation.
    Fritz KS
    Methods Mol Biol; 2013; 1077():191-201. PubMed ID: 24014408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional interaction of histone deacetylase 5 (HDAC5) and lysine-specific demethylase 1 (LSD1) promotes breast cancer progression.
    Cao C; Vasilatos SN; Bhargava R; Fine JL; Oesterreich S; Davidson NE; Huang Y
    Oncogene; 2017 Jan; 36(1):133-145. PubMed ID: 27212032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An in vitro investigation of metabolically sensitive biomarkers in breast cancer progression.
    Simpson NE; Tryndyak VP; Beland FA; Pogribny IP
    Breast Cancer Res Treat; 2012 Jun; 133(3):959-68. PubMed ID: 22101407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.